Dorian LPG
LPG
DOMINOS PIZZA ENTERPRISES LIMITED UNSP ADR EACH REPR 0.5 ORD SHS
DMZPY
AIRPORTS OF THAILAND PUBLIC CO UNSP ADR EACH REP 10 ORD SHS
AIPUY
eBay
EBAY
Lantheus
LNTH
US Stock MarketDetailed Quotes
AKBA Akebia Therapeutics
- 1.7600
- -0.1100-5.88%
Close Dec 18 16:00 ET
- 1.8000
- +0.0400+2.27%
Pre 08:35 ET
384.00MMarket Cap-8.00P/E (TTM)
1.9000High1.7400Low2.70MVolume1.8800Open1.8700Pre Close4.92MTurnover1.36%Turnover RatioLossP/E (Static)218.18MShares2.480052wk High-7.62P/B348.96MFloat Cap0.800052wk Low--Dividend TTM198.27MShs Float31.0000Historical High--Div YieldTTM8.56%Amplitude0.2410Historical Low1.8220Avg Price1Lot Size
About Akebia Therapeutics Company
Akebia Therapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapeutics for patients with kidney diseases. The firm is also involved in the development and commercialization of drugs for the treatment of renal and metabolic disorders. Its products include Auryxia and Vadadustat. The company was founded by Joseph H. Gardner, John M. Rice, Michael E. Pape, Josh P. Fairbank, and Robert A. Shalwitz on February 27, 2007 and is headquartered in Cambridge, MA.
Company Profile
SymbolAKBA
Company NameAkebia Therapeutics
Listing DateMar 20, 2014
Issue Price17.00
Founded2007
CEOMr. John P. Butler
MarketNASDAQ
Employees167
Fiscal Year Ends12-31
Address245 First Street,Suite 1400
CityCambridge
ProvinceMassachusetts
CountryUnited States of America
Zip Code02142
Phone1-617-871-2098
Websitehttp://www.akebia.com
Company Executives
- Name
- Position
- Salary
- John P. Butler
- Director, President and Chief Executive Officer
- 2.78M
- Erik John Ostrowski
- Senior Vice President, Chief Financial Officer, Chief Business Officer and Treasurer
- --
- Richard C. Malabre
- Chief Accounting Officer
- --
- Nicholas Grund
- Senior Vice President and Chief Commercial Officer
- --
- Dr. Steven Keith Burke, M.D.
- Senior Vice President, Research and Development and Chief Medical Officer
- 1.21M
- Adrian Adams
- Chairman of the Board
- 171.63K
- Dr. Myles Wolf, M.D.
- Independent Director
- 144.43K
- Ronald E. Frieson
- Independent Director
- 147.97K
- Michael W. Rogers
- Independent Director
- 145.79K
- Cynthia Smith
- Independent Director
- 151.50K
- Dr. Steven C. Gilman, PhD
- Independent Director
- 139.87K
- LeAnne M. Zumwalt
- Independent Director
- 143.31K